CurrentRheuma
Get Weekly

Topic · page 7 of 7

Sjögren's disease & overlap diseases

Sjögren's disease, its glandular and extraglandular disease and lymphoma risk; mixed, undifferentiated and overlap connective tissue disease

Briefs 241–272 of 272 placed here, newest publication first

Briefs in Sjögren's disease & overlap diseases

Newest publication first

  1. RMD Open

    Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren’s syndrome

    Cross-sectional study

  2. Arthritis Res Ther

    Serum vitamin D levels and Sjogren’s syndrome: bi-directional Mendelian randomization analysis

    Research article

  3. Lancet Rheumatol

    Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

    Cohort study

  4. Ann Rheum Dis

    Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B

    Case-control study

  5. RMD Open

    Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren’s syndrome

    Mechanistic study

  6. Arthritis Rheumatol

    Association of Circulating Antibody‐Secreting Cell Maturity With Disease Features in Primary Sjögren's Syndrome

    Cross-sectional study

  7. RMD Open

    Development and testing of an alternative responder definition for EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI)

    Diagnostic or prognostic study

  8. RMD Open

    Impact of patient ancestry on heterogeneity of Sjögren’s disease

    Case-control study

  9. Clin Exp Rheumatol

    Significant association of CX3CR1+CD8 T cells with aging and distinct clinical features in Sjögren's syndrome and IgG4-related disease

    Cross-sectional study

  10. Rheumatology (Oxford)

    Identification of new candidate drugs for primary Sjögren’s syndrome using a drug repurposing transcriptomic approach

    Cohort study

  11. Rheumatology (Oxford)

    A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjögren’s syndrome

    Randomized controlled trial

  12. RMD Open

    Phosphorylated signal transducer and activator of transcription proteins 1 in salivary glandular tissue: an important histological marker for diagnosis of primary Sjögren’s syndrome

    Diagnostic or prognostic study

  13. Clin Exp Rheumatol

    The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis

    Meta-analysis

  14. Clin Exp Rheumatol

    Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme

    Cross-sectional study

  15. Joint Bone Spine

    Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study

    Cross-sectional study

  16. Arthritis Res Ther

    Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis

    Cohort study

  17. Rheumatology (Oxford)

    FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren’s syndrome

    Diagnostic or prognostic study

  18. Rheumatology (Oxford)

    In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study

    Cohort study

  19. Rheumatology (Oxford)

    Fetal–neonatal and maternal outcomes in women with Sjögren syndrome: a population-based registry linkage study

    Cohort study

  20. Rheumatology (Oxford)

    Ultrasound-guided core needle biopsy and incisional biopsy of the parotid gland are comparable in diagnosis of primary Sjögren’s syndrome

    Diagnostic or prognostic study

  21. Rheumatology (Oxford)

    Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program

    Cohort study

  22. Clin Exp Rheumatol

    Kynurenine pathway can be a potential biomarker of fatigue in primary Sjögren's syndrome

    Cross-sectional study

  23. Clin Exp Rheumatol

    Anticentromere antibody positive patients with primary Sjögren's syndrome have distinctive clinical and immunological characteristics

    Cohort study

  24. Clin Exp Rheumatol

    Clinical and prognostic features associated with anti-Ro52 autoantibodies in connective tissue diseases patients with interstitial lung disease

    Cohort study

  25. Ann Rheum Dis

    Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity

    Mechanistic study

  26. Joint Bone Spine

    Diagnostic utility of a second minor salivary gland biopsy in patients with suspected Sjögren's syndrome: A retrospective cohort study

    Cohort study

  27. Rheumatology (Oxford)

    Anti-PM-Scl antibodies–positive patients encompass three different groups with distinct prognoses

    Cohort study

  28. Rheumatology (Oxford)

    Predicting lymphoma in Sjögren’s syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording

    Case-control study

  29. Clin Exp Rheumatol

    Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study

    Cohort study

  30. Rheumatology (Oxford)

    TOX promotes follicular helper T cell differentiation in patients with primary Sjögren’s syndrome

    Mechanistic study

  31. Scand J Rheumatol

    Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres

    Cohort study

  32. Scand J Rheumatol

    Serum CCL28 as a biomarker for diagnosis and evaluation of Sjögren’s syndrome

    Cross-sectional study

All 272 Briefs in ExploreShowing Briefs 241–272 of 272, newest first